StacksVerified U.S. regulatory reference

21 CFR §332.31

Verified against eCFR.gov as of June 20, 2026View official text on eCFR.gov ↗
  1. (a)The labeling of the product provided to health professionals (but not to the general public) may contain as additional indications postoperative gas pain or for use in endoscopic examination.
  2. (b)Professional labeling for an antiflatulent-antacid combination may contain information allowed for health professionals for antacids and antiflatulents.